Literature DB >> 30699003

Doxapram stimulates respiratory activity through distinct activation of neurons in the nucleus hypoglossus and the pre-Bötzinger complex.

Sandra Kruszynski1, Kornelijus Stanaitis2, Janine Brandes2, Christian F Poets1, Henner Koch2.   

Abstract

Doxapram is a respiratory stimulant used for decades as a treatment option in apnea of prematurity refractory to methylxanthine treatment. Its mode of action, however, is still poorly understood. We investigated direct effects of doxapram on the pre-Bötzinger complex (PreBötC) and on a downstream motor output system, the hypoglossal nucleus (XII), in the transverse brainstem slice preparation. While doxapram has only a modest stimulatory effect on frequency of activity generated within the PreBötC, a much more robust increase in the amplitude of population activity in the subsequent motor output generated in the XII was observed. In whole cell patch-clamp recordings of PreBötC and XII neurons, we confirmed significantly increased firing of evoked action potentials in XII neurons in the presence of doxapram, while PreBötC neurons showed no significant alteration in firing properties. Interestingly, the amplitude of activity in the motor output was not increased in the presence of doxapram compared with control conditions during hypoxia. We conclude that part of the stimulatory effects of doxapram is caused by direct input on brainstem centers with differential effects on the rhythm generating kernel (PreBötC) and the downstream motor output (XII). NEW & NOTEWORTHY The clinically used respiratory stimulant doxapram has distinct effects on the rhythm generating kernel (pre-Bötzinger complex) and motor output centers (nucleus hypoglossus). These effects are obliterated during hypoxia and are mediated by distinct changes in the intrinsic properties of neurons of the nucleus hypoglossus and synaptic transmission received by pre-Bötzinger complex neurons.

Entities:  

Keywords:  apnea of prematurity; hypoxia; respiration

Mesh:

Substances:

Year:  2019        PMID: 30699003     DOI: 10.1152/jn.00304.2018

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  2 in total

Review 1.  Countering opioid-induced respiratory depression by non-opioids that are respiratory stimulants.

Authors:  Mohammad Zafar Imam; Andy Kuo; Maree T Smith
Journal:  F1000Res       Date:  2020-02-07

2.  Doxapram alleviates low SpO2 induced by the combination of propofol and fentanyl during painless gastrointestinal endoscopy.

Authors:  Zhengfeng Gu; Lian Xin; Haoxing Wang; Chunxiao Hu; Zhiping Wang; Shunmei Lu; Jingjing Xu; Yiling Qian; Jun Wang
Journal:  BMC Anesthesiol       Date:  2019-11-22       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.